GB0604772D0 - Use of substituted amine compounds for the treatment of food related disorders - Google Patents

Use of substituted amine compounds for the treatment of food related disorders

Info

Publication number
GB0604772D0
GB0604772D0 GBGB0604772.4A GB0604772A GB0604772D0 GB 0604772 D0 GB0604772 D0 GB 0604772D0 GB 0604772 A GB0604772 A GB 0604772A GB 0604772 D0 GB0604772 D0 GB 0604772D0
Authority
GB
United Kingdom
Prior art keywords
treatment
related disorders
amine compounds
substituted amine
food related
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0604772.4A
Other versions
GB2435824A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Laboratorios del Dr Esteve SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios del Dr Esteve SA filed Critical Laboratorios del Dr Esteve SA
Priority to GB0604772A priority Critical patent/GB2435824A/en
Publication of GB0604772D0 publication Critical patent/GB0604772D0/en
Publication of GB2435824A publication Critical patent/GB2435824A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0604772A 2006-03-09 2006-03-09 Use of nitrile compounds in the treatment of food related and other disorders Withdrawn GB2435824A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0604772A GB2435824A (en) 2006-03-09 2006-03-09 Use of nitrile compounds in the treatment of food related and other disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0604772A GB2435824A (en) 2006-03-09 2006-03-09 Use of nitrile compounds in the treatment of food related and other disorders

Publications (2)

Publication Number Publication Date
GB0604772D0 true GB0604772D0 (en) 2006-04-19
GB2435824A GB2435824A (en) 2007-09-12

Family

ID=36241296

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0604772A Withdrawn GB2435824A (en) 2006-03-09 2006-03-09 Use of nitrile compounds in the treatment of food related and other disorders

Country Status (1)

Country Link
GB (1) GB2435824A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2170050T3 (en) 2007-06-20 2014-09-29 Milestone Pharmaceuticals Inc Short-acting phenylalkylamine-calcium channel blockers and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3603032A1 (en) * 1986-01-31 1987-08-06 Basf Ag BASICLY SUBSTITUTED PHENYL ACETONITRILES, THEIR PRODUCTION AND THE MEDICINAL PRODUCTS CONTAINING THEM
CA2007525A1 (en) * 1989-01-30 1990-07-30 Zola P. Horovitz Method for facilating dieting employing an ace inhibitor
FR2717473B1 (en) * 1994-03-16 1996-06-28 Esteve Labor Dr Cyclopropylacetonitrile derivatives, their preparation and their use as medicaments.

Also Published As

Publication number Publication date
GB2435824A (en) 2007-09-12

Similar Documents

Publication Publication Date Title
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
EP1976377A4 (en) Compounds for the treatment of metabolic disorders
IL185016A0 (en) Compounds for the treatment of proliferative disorders
ZA200806074B (en) Compounds for the treatment of inflammatory disorders
EP1983972A4 (en) Compounds for the treatment of metabolic disorders
IL195203A0 (en) Compounds for the treatment of metabolic disorders
AU2008281877A8 (en) The use of benzamide derivatives for the treatment of CNS disorders
EP1853539A4 (en) Honokiol derivatives for the treatment of proliferative disorders
HK1131141A1 (en) Imidazolothiazole compounds for the treatment of disease
HK1119577A1 (en) Compounds for the treatment of metabolic disorders
EP1901733A4 (en) Use of huperzine for disorders
EP2139475A4 (en) The use of pde7 inhibitors for the treatment of movement disorders
IL192852A0 (en) Compounds for the treatment of metabolic disorders
ZA200806455B (en) Use of 2-imidazoles for the treatment of CNS disorders
GB0604780D0 (en) Use of substituted piperazine compounds for the treatment of food related disorders
IL192877A0 (en) Use of 2-imidazoles for the treatment of cns disorders
IL192851A0 (en) Compounds for the treatment of metabolic disorders
GB0604781D0 (en) Use of substituted phenyl-piperazine compounds for the treatment of food related disorders
IL195392A0 (en) Compounds for the treatment of metabolic disorders
EP2099444A4 (en) Use of d-serine derivatives for the treatment of anxiety disorders
PL1982178T3 (en) Methods for the treatment of affective disorders
GB0604782D0 (en) Use of substituted pyrimidinyl-2-piperazine compounds for the treatment of food related disorders
GB0604772D0 (en) Use of substituted amine compounds for the treatment of food related disorders
HK1129112A1 (en) 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders
GB0604783D0 (en) Use of substituted oxime compounds for the treatment of food related disorders

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)